SOURCE-LINKED INTELLIGENCE
Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
w launching a phase 1 clinical trial just after the project. Type 1 diabetes, autoimmune disease, immune-mediated disease, cell therapy, gene therapy, regulatory T cells, medical product development, machine learning
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 6998037.5
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T01:21:06.728Z. This is not the publication date.